Free tool
Stocks above their 200-day average
We cover 25 companies trading above their own 200-day average. The median market value in the group is $7.28B. Across the group, the median move over the past trading day is −0.85%. 100% of the 25 with a 200-day average trade above it. Price change over the past year runs from −9.9% to +62.9% across the middle 80 percent of the group, with a median of +13.4%.
Other lists in this group
Table
25 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.